Patents by Inventor Kristina REHMET

Kristina REHMET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EHV insertion site UL43
    Patent number: 11596681
    Abstract: The present invention relates to the field of (vector) vaccines, and especially to the novel EHV insertion site UL43. The present invention further concerns related expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: March 7, 2023
    Inventors: Alice Mundt, Andreas Gallei, Kristina Rehmet
  • Promoters
    Patent number: 11261464
    Abstract: The present invention relates to the field of (vector) vaccines, and especially to novel promoter sequences, expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: March 1, 2022
    Inventors: Alice Mundt, Andreas Gallei, Ramesh Koukuntla, Robert Barry Mandell, Kristina Rehmet, Eric Martin Vaughn
  • NEW EHV INSERTION SITE UL43
    Publication number: 20210100890
    Abstract: The present invention relates to the field of (vector) vaccines, and especially to the novel EHV insertion site UL43. The present invention further concerns related expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.
    Type: Application
    Filed: March 19, 2019
    Publication date: April 8, 2021
    Inventors: Alice MUNDT, Andreas GALLEI, Kristina REHMET
  • EHV insertion site ORF70
    Patent number: 10619169
    Abstract: The present invention relates to the field of (vector) vaccines, and especially to the novel EHV insertion site ORF70. The present invention further concerns related expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: April 14, 2020
    Inventors: Alice Mundt, Andreas Gallei, Kristina Rehmet
  • Canine adenovirus vectors
    Patent number: 10329586
    Abstract: The present invention relates to the field of CAdV vector vaccines, and especially to promoters suitable to express target antigens from such vector vaccines. Disclosed and claimed are recombinant canine adenoviruses, methods of making them, uses for them (including in immunological, immunogenic, vaccine or therapeutic compositions, or, as a vector for cloning, replicating or expressing DNA and methods of using the compositions and vector), expression products from them, and uses for the expression products. Additionally, disclosed and claimed are truncated EHV4 promoters, expression cassettes containing the promoters, and recombinant viruses and plasmids containing the promoters or expression cassettes.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: June 25, 2019
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Andreas Gallei, Ramesh Koukuntla, Robert Barry Mandell, Alice Mundt, Kristina Rehmet, Eric Martin Vaughn
  • PROMOTERS
    Publication number: 20180080047
    Abstract: The present invention relates to the field of (vector) vaccines, and especially to novel promoter sequences, expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.
    Type: Application
    Filed: September 18, 2017
    Publication date: March 22, 2018
    Inventors: Alice MUNDT, Andreas GALLEI, Ramesh KOUKUNTLA, Robert Barry MANDELL, Kristina REHMET, Eric Martin VAUGHN
  • CANINE ADENOVIRUS VECTORS
    Publication number: 20180080045
    Abstract: The present invention relates to the field of CAdV vector vaccines, and especially to promoters suitable to express target antigens from such vector vaccines. Disclosed and claimed are recombinant canine adenoviruses, methods of making them, uses for them (including in immunological, immunogenic, vaccine or therapeutic compositions, or, as a vector for cloning, replicating or expressing DNA and methods of using the compositions and vector), expression products from them, and uses for the expression products. Additionally, disclosed and claimed are truncated EHV4 promoters, expression cassettes containing the promoters, and recombinant viruses and plasmids containing the promoters or expression cassettes.
    Type: Application
    Filed: September 18, 2017
    Publication date: March 22, 2018
    Inventors: Andreas GALLEI, Ramesh KOUKUNTLA, Robert Barry MANDELL, Alice MUNDT, Kristina REHMET, Eric Martin VAUGHN
  • EHV INSERTION SITE ORF70
    Publication number: 20180080043
    Abstract: The present invention relates to the field of (vector) vaccines, and especially to the novel EHV insertion site ORF70. The present invention further concerns related expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.
    Type: Application
    Filed: September 18, 2017
    Publication date: March 22, 2018
    Inventors: Alice MUNDT, Andreas GALLEI, Kristina REHMET